When can Reductil (Sibutramine) be prescribed to help weight loss (obesity)?
Reductil is licensed as adjunctive therapy within a weight management programme aimed to promote weight loss. It is a prescription only medicine which can be prescribed for obese patients with a body mass index (BMI) of greater than 30 kg/m 2 or for overweight patients with a body mass index (BMI) of greater than 27 kg/m 2 who also have other risk factors such as type 2 diabetes or dyslipidaemia (a disturbance in the levels of fat (lipids) in the blood). Reductil may only be prescribed to patients who have tried to lose weight by diet and exercise for 3 months or more and have been unsuccessful in losing at least 5% of their body weight. It can only be used under the ongoing care of a doctor experienced in the treatment of obesity.